Should You Buy RXO Inc (RXO) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/26
RXO Inc. is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive indicators such as insider buying and potential future market recovery, the company's weak financial performance, mixed analyst sentiment, and lack of strong trading signals suggest a cautious approach. Holding the stock or waiting for clearer signs of improvement is advisable.
Technical Analysis
The MACD is positive at 0.163, indicating mild bullish momentum, but it is contracting. RSI is neutral at 62.478, and moving averages are converging, suggesting no strong trend. The stock is trading near its resistance level (R1: 16.004), which may limit immediate upside potential.
Analyst Ratings and Price Target Trends
Analyst sentiment is mixed. Recent upgrades include Wolfe Research upgrading to Peer Perform and Morgan Stanley upgrading to Overweight, citing RXO's AI strategy and valuation. However, several firms, including Citi and UBS, have lowered price targets, and Susquehanna maintains a Negative rating. Price targets range from $10 to $19, with most analysts adopting a cautious outlook for near-term performance.
Wall Street analysts forecast RXO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RXO is 15.42 USD with a low forecast of 11 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast RXO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RXO is 15.42 USD with a low forecast of 11 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 14.600
Current: 14.600
